Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-06-29 CHA ALBERT Director Grant or award · Stock Option (right to buy) +6,632 6,632
2015-10-13 CHA ALBERT Director Conversion +3,433,646 3,736,852
2015-10-13 CHA ALBERT Director Purchase +454,545 $11.00 $5.0M 4,191,397
2015-10-13 CHA ALBERT Director Conversion · Series A Preferred Stock −8,652,500 0
2015-10-13 CHA ALBERT Director Conversion · Series B Preferred Stock −1,818,182 0
2015-10-13 CHA ALBERT Director Conversion · Series C Preferred Stock −1,375,405 0
2015-10-07 CHA ALBERT Director Purchase +13,352 $11.00 $147K 303,206

Page 1 of 1 · 7 trades